131 related articles for article (PubMed ID: 27583691)
1. Skin Lesions and Recurrent Fever in Acute Myeloid Leukemia Patient Treated With Allogeneic Stem Cell Transplant.
Yun S; Vincelette ND
JAMA Oncol; 2016 Dec; 2(12):1649-1650. PubMed ID: 27583691
[No Abstract] [Full Text] [Related]
2. A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient.
Lam W; Viswabandya A; Hussain S; Messner HA; Michelis FV; Kim DD; Lipton JH; Deotare U
Bone Marrow Transplant; 2016 Oct; 51(10):1385-1386. PubMed ID: 27183093
[No Abstract] [Full Text] [Related]
3. Adoptive transfer of vitiligo after allogeneic peripheral blood stem cell transplant.
Campbell-Fontaine A; Coad JE; Kovach R; Ericson SG
Bone Marrow Transplant; 2005 Oct; 36(8):745-6. PubMed ID: 16113666
[No Abstract] [Full Text] [Related]
4. Cerebral tuberculosis post stem cell transplant.
Bloor AJ; Mackinnon S
Eur J Haematol; 2006 Nov; 77(5):456. PubMed ID: 16856918
[No Abstract] [Full Text] [Related]
5. Wernicke's encephalopathy after allogeneic stem cell transplantation.
Baek JH; Sohn SK; Kim DH; Kim JG; Lee HW; Park SP; Lee KB
Bone Marrow Transplant; 2005 Apr; 35(8):829-30. PubMed ID: 15750604
[No Abstract] [Full Text] [Related]
6. Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature.
Henrich TJ; Marty FM; Milner DA; Thorner AR
Transpl Infect Dis; 2009 Oct; 11(5):458-62. PubMed ID: 19804480
[TBL] [Abstract][Full Text] [Related]
7. Delayed human herpes virus 6 encephalitis in a patient with allogeneic stem cell transplant.
O'Toole J; Ades S; Waters BL; Agarwal Z; Lamba G
Leuk Lymphoma; 2015; 56(9):2709-10. PubMed ID: 25629987
[No Abstract] [Full Text] [Related]
8. A "body armor" of leukemia cutis.
Janssen NA; Hebeda KM; Stevens WB; van der Velden WJ
Am J Hematol; 2015 Aug; 90(8):751. PubMed ID: 25611338
[No Abstract] [Full Text] [Related]
9. Angiomatous nodules acquired after allogeneic stem cell transplantation.
Braun-Falco M; Menzel H
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):123-4. PubMed ID: 18181994
[No Abstract] [Full Text] [Related]
10. Rapidly fatal post-allogeneic stem cell transplant lymphoproliferative disorder presenting with skin and bone marrow involvement.
Gasiorowski R; Gibson J; Watson G; Trotman J; Larsen S
Pathology; 2013 Jan; 45(1):81-3. PubMed ID: 23255032
[No Abstract] [Full Text] [Related]
11. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR
Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531
[TBL] [Abstract][Full Text] [Related]
12. Multiple pretibial cutaneous relapses of acute myeloblastic leukemia after allogeneic BMT.
Juárez A; Goiriz R; Domínguez-Fernández I; Gómez-García de Soria V; Cámara R; Fraga J; García-Diez A
Bone Marrow Transplant; 2009 May; 43(10):819-20. PubMed ID: 19169285
[No Abstract] [Full Text] [Related]
13. Photo quiz. Dyspnea and fever in an allogeneic stem cell recipient.
Angoulvant A; Stern JB; Wittnebel S; Bourhis JH; Gachot B; Vittecoq D; Wyplosz B
Clin Infect Dis; 2015 Jan; 60(1):100, 157-8. PubMed ID: 25504499
[No Abstract] [Full Text] [Related]
14. Leukemia burden and outcome of allogeneic transplant in acute myelogenous leukemia.
Kamble RT; Hjortsvang E; Selby GB
Biol Blood Marrow Transplant; 2006 Jun; 12(6):691-2. PubMed ID: 16737944
[No Abstract] [Full Text] [Related]
15. Simultaneous acute myeloid leukemia and multiple myeloma successfully treated with allogeneic stem cell transplantation.
Kim D; Kwok B; Steinberg A
South Med J; 2010 Dec; 103(12):1246-9. PubMed ID: 21037523
[TBL] [Abstract][Full Text] [Related]
16. Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Yeshurun M; Labopin M; Blaise D; Cornelissen JJ; Sengeloev H; Vindelov L; Kuball J; Chevallier P; Craddock C; Socie G; Bilger K; Schouten HC; Fegueux N; Goker H; Maertens J; Bunjes D; Arnold R; Nagler A; Mohty M
Cancer; 2014 Mar; 120(6):855-63. PubMed ID: 24338939
[TBL] [Abstract][Full Text] [Related]
17. Postallogeneic hematopoietic stem cell transplantation relapse of acute myeloid leukemia presenting with salivary gland myelosarcoma.
Lai YH; Chang CS; Liu YC; Liu TC
Ann Hematol; 2010 Jun; 89(6):631-3. PubMed ID: 19816683
[No Abstract] [Full Text] [Related]
18. Lethal cardiac and cerebral toxoplasmosis in a patient with acute myeloid leukemia after successful allogeneic bone marrow transplantation.
Jehn U; Fink M; Gundlach P; Schwab WD; Bise K; Deckstein WD; Wilske B
Transplantation; 1984 Oct; 38(4):430-3. PubMed ID: 6388067
[No Abstract] [Full Text] [Related]
19. Metastatic squamous cell carcinoma in a bone marrow transplant recipient.
Mittal C; Hassan S; Mattour A; Janakiraman N
Hematol Oncol Stem Cell Ther; 2013 Mar; 6(1):46-7. PubMed ID: 23664606
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
Ganguly S; Divine CL; Aljitawi OS; Abhyankar S; McGuirk JP; Graves L
Clin Transplant; 2012; 26(3):447-53. PubMed ID: 22003964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
